The advent of the multiwavelength anomalousdiffraction phasing methodhas significantlyacceleratedcrystal structuredeterminationand hasbecomethe norm in protein crystallography. This method allowsresearchersto takeadvantageofthe anomalous signal fromdivers eatoms,but thedominantmethod forderivativ epreparation is selenomethionine substitution.S everal generallya pplicable, high-efficiency labeling protocolsh aveb een developed for use in the bacterial, yeast, andbaculovirus/insect cell expressionsystems butnot formammalian tissuec ulture.A sal arge number of proteinso fb iomedical importance cano nlyb ep roducedi ny ields sufficient forX -ray diffraction experimentsi nm ammalian expression systems, it becomesa ll them ore importantt od evelops uchp rotocols.W et herefore evaluateds everal variablest hatp lay roles in determining incorporation levels andr eporth ere as imple protocolf or selenom ethionine modification of proteinsi n mammalian cellsr outinely yielding >90%l abeling efficiency.
The multiwavelength anomalous diffraction (MAD)phasingm ethod (Hendrickson1 991) hasb ecome them ethod of choice for X-ray phase determination, with >50% of thee xperimentally phased structures deposited in the PDB during thep asty ear beingd etermined by MAD. WhileM AD has allowed researchers to take advantage of thea nomalouss ignal from several diverse heavy atoms, thed ominantm ethodf or heavya tomd erivative preparation is selenomethioninesubstitution. Several factors contribute to the widespread use of selenomethionine substitution, including simplicity, adaptabilitytodifferent expression systems, scalability,a nd, in some cases, an almost quantitative replacement of methionine resulting in ahomogeneousprotein population. This method results in modified proteins withoutsignificantstructural perturbations due to heavy atom incorporation,w hile eliminatingthe difficult and time-consuming screenings forheavy atom derivatives.
It is estimated that, foras uccessful MADe xperiment, ones elenomethionine residue is required for every ; 75-100a mino acids (Hendrickson andO gata 1997) . This corresponds to ; 80%o fa ll proteins, which have am ethioninecontentof1%ormore (Strub et al.2003) . There are twol imitations to the method: First, the calculations abovea ssumeq uantitative( or near-quantitative) methionine substitution, which often is not the case.F or example, as the complexity of the expression system host increases, so does the complexity of the media requiredfor their growth, while the efficiency of incorporation decreasesc oncomitantly.S econd, the selenomethionines mustb eo rdered in the crystal. Methioninesa re often located in the hydrophobic proteincore and are thus likely to be ordered, but there is no assurancet hat this is always the case. While it is difficult to predict ap riori or to compensate for side-chain disorder,techniques can be improved to maximizethe efficiency of selenomethionine incorporation.
The production of selenomethionine-labeled proteins has been reported in CHOc ells (Wue ta l. 1994; Lustbader et al. 1995) , but up to now, no general protocol was availablef or the efficient preparation and accurate analysis of selenomethionine-substituted proteins produced from mammalian cell culture. Since many of our crystallographic experiments involveproteins secreted from stably transfected mammalian cell lines, we developed, optimized, and reporthere aprotocol for the routine selenomethionine incorporation at the 90%s ubstitution level.W ea lso describe am ethod for assessment of the labeling efficiency usingm atrix-assisted laserd esorptioni onizationm asss pectrometryt echnology( MALDI-TOF).
Results
We evaluatedm ultiple variables that couldp otentially contributet ot he efficiencyo fs elenomethionine incorporation, including extento fm ethionine depletionp rior to addition of selenomethionine, length of timei nt he presence of selenomethionine, amount of selenomethionine in the growth media, andt ype of serum used during labeling.T od etermine the effect of each of these variables, we designed eighti ndependent labeling experiments using ah umane mbryonick idney (HEK293)c elll ine expressing,a sasecreted protein, the ligand-binding domain of the humanr eceptort yrosine kinase Tie2. Cells were evenly split into1 5-cm culturep lates and allowed to grow to ; 80%-90% confluence. The growth media were aspirated from the plates and replacedw ith one medium lacking methionine, and the cultures werei ncubated for either 6or12h.Preincubation in the absence of methionine serves to depleteintracellular methionine pools(whichcould effectively competef or tRNAa ctivation during selenomethionine labeling) and alsop ermits the cellt os ecreteo r degrade any remaining unlabeled recombinant protein that is undergoing folding or translocation through the endoplasmicr eticulum and the Golgi.F ollowing this short preincubation, the media were changedt oi nclude either 30 or 60 mg/L of selenomethionine and 10% of either dialyzed or nondialyzed fetal bovine serum. The dialyzed serum containslower concentrations of small molecules, including amino acids such as methionine that couldcompete for protein incorporation. Thea mounts of added selenomethionine were based on the amount of methionine present in classical Dulbecco'sm odified Eagle'sm edium (DMEM). Subsequent to the addition of selenomethionine-containing media, the cells werea llowed to incubate another 72 h, and then harvested.
The recombinant Tie2-Fc was purified from them edia usingt he batch methodw ith Protein A-Sepharose beads (Materialsa nd Methods).T ie2w as cleaved offt he beads with thrombin and resolved on SDS-PAGE. Under these conditions, they ield of selenomethionine-labeled protein variedf rom ; 60%t o8 0% of that of the unlabeled protein. Control( unlabeled) ands elenomethionine-labeled and SDS-PAGE-purified protein samples were digested with trypsin, and peptides werea nalyzed by MALDIReTOFa nd TOF/TOF mass spectrometry.T he N-terminal fragment (amino acidr esidues1 -452) of the humanT ie2 receptor (NCBI no. 4,557,869)was positively identified on the basis of peptide massf ingerprint (PMF) result (36% sequence coverage; Mowse scoreof7 9, where as core >63 is significant) and Mascot MS/MS scoreo f1 07 (protein scores >76 are significant hits) of the selected tryptic peptide at m/z ¼ 1446.74 with sequence YIGGNLFT SAFTR. The mass spectra obtained from the unlabeled (control) and selenomethionine-labeledp roteins were compared for differences. Ap eptide at 2534.1 amu was observed in the proteins amples enrichedw ith selenomethionine (samples 2-8) but was absenti nt he unlabeled control sample (Fig. 1A ). This peptide maps to the predicted, selenomethionine-enriched peptide with sequence DFEALMNQHQDPLEVTQDVTR, encompassing Met-65 and assuming the selenomethionine enrichment (MH+ 2486.15 +4 7.95 to account for am ass difference duet o replacement of sulfur with selenium). The identity of the modified peptide was confirmed by carrying out MALDI-TOF/TOF MS/MS on selected peaks at m/z ¼ 2534 (Fig.  1B) and 2486 (Fig. 1C) , respectively. Finally, the selenium enrichment/incorporationl evels of each preparation were individually calculated by integrating the areas of the peaks corresponding to the unmodified peptide at 2486.15 amu and the modified peptide at 2534.10 amu.
Table1summarizes thec ulturec onditionst hatw ere used and thec orresponding selenomethioninei ncorporation efficiency. Interestingly, thet ypeo fs erum (dialyzed or standard serum) did nots ignificantly change the efficiency of incorporation, indicating that fetalb ovine serumm ay containl ower levels of free aminoa cids than previously thought. Thelengthofpreincubation time used to depletei ntracellular methionine poolsp rior to addition of selenomethionine also hadarelatively smalleffectonincorporation efficiencies.I nstead,w ef ound that thea mounto f selenomethionine presenti nt he growth mediah ad them ost profound effect on thee xtento fs elenomethionine substitution.U nfortunately,w hile high levels of incorporationa re seen in thep resenceo fl argerc oncentrationso fs elenomethionine,t oxicitya lsoi ncreases substantially, andp rotein yields decrease concurrently.T akinge ach of thesep aram- eters into account, we haveo ptimized ourp rotocol to maximizet he concentration of added selenomethionine andt he preincubationt imeinmethionine-free media, while minimizing their toxicity to the mammalian cells. Specifically,w es uggesta so ptimal ap rotein-labeling procedure that includesa1 2-h preincubation, subsequent addition of 60 mg/L selenomethionine, and continuousc ellg rowth in undialyzed fetal bovine serum.
As proof of principle to the applicability of this labeling method to crystallographic phased etermination, we have recentlydetermined thestructure of an extracellular test protein produced in mammalian cells using SAD phases from acrystalcontaining ; 93% selenomethionine substitution at 1.8Å resolution (Fig. 2) . Our test protein (the receptor-binding region of Angiopoietin-2) contained four methioninesi n2 15 amino acidsw ithf our copies of the proteinm onomer in the crystal asymmetricu nit. The resultinge lectron density maps were of excellent quality (seeFig. 3) andallowed ; 90%ofthe structure to be built automaticallyv ia ARP/warp( CCP4 1994). Largea mounts (tens of milligrams) of labeled Angiopoietin-2 were produced in mammalianc ell cultureu sing the optimized protocolo utlineda bove.S pecifically, stably transfected2 93 cellsw ere grown to ; 90% confluence in roller-bottle culture and washed briefly with as mall amount of PBS prior to the addition of depletion media containing no additional methionine. Following a1 2-h incubation, the media were exchanged for fresh media containing 60 mg/L selenomethionine. Theculturewas continued for ; 48 h, at which time the viability of the cells had decreased dramatically,a nd theyh ad begun detaching from the culture vessel. Thep rotein yield was ; 50% of that in standard DMEM. Our experiments indicate that in rollerbottle culture, the HEK293 cells are significantly more sensitive to the toxic effects of selenomethionine than in stationarym onolayer cultures. We therefore suggest culturing with selenomethionine for ; 48 hi nr oller-bottles and for ; 72 hindishes. Following purification, the labeled Ang2-RBDbehaved similarly to the wild-type protein with respect to crystallization, and well-diffracting crystals were easily obtained.The structurewas determinedusing asinglewavelength data sett hatw as collecteda tt he selenium Ka bsorptione dge.
Discussion
As part of these studies, we evaluateds everalg rowth variables andi dentified the optimal conditions (based on MALDI-TOF estimates for incorporationl evels) for selenomethionine incorporation into proteins produced in mammalianc ellc ulture.T he data document that efficiency of incorporation is dominated by the amount of label available. This coulde asily be explained by mass action rules, as the highert he concentration of selenomethionine is, the lessc ompetitive effect the intracellular methionine will have. However,selenomethionine is toxicinhigh concentrations, and increasing its amount in the growth media comes with ac oncomitant decrease in cell viability and, consecutively,protein yield. For crystallographic studies,in Under the evaluated conditions, the yield of labeled protein was 60%-80% of that of the unlabeled one. which as mall amount of protein is sufficient for crystallization andp hase determination, proteiny ield mayn ot representa ni ssue of concern. However, if onen eeds to screen forcrystallizationconditionsfollowing labeling,lower concentrations of selenomethionine (20-30 mg/L)may need to be used to increase proteiny ield at thec osto fh aving loweri ncorporation efficiency.T he length of preincubation in thea bsence of methionine (methionined epletion)a lso playsasmall butsignificant role,withanoptimal time of 12 h. Incubationsl ongert han1 2hd ecreasec ellv iability (data nots hown)a nd,t herefore,a re notr ecommended. In additiontoAng2and Tie2 discussedabove,wehave used theprotocol presentedh eretoproduce several other selenomethionine-labeled secretedp roteins in ourl aboratory,including netrin-1, plexinB3,and theectodomains of ADAM10 and EphA3 (data nots hown). In allc ases, incorporatione fficiencieso f8 5% or higher were achieved, with expression yields sufficient forcrystallographicstudies. The protocol is also highly suitable forh igh-throughput/ structural-genomics applications as it is portable, scalable, and flexible, and adaptable to the growth of different cell typesunder avariety of cell growth conditions.For example, efficient labeling canbeperformed in CHO, HEK293,COS, or anyo ther mammalianc ellt ypeg rown in serum-free mediao ri ns erum-supplemented media.
To increase evenf urther the repertoire of proteins amenable to selenomethionine-based MAD phasing, it should be possible to expand them ethodology reported here to includeac omplementary dual labelinga pproach that hasr ecently been applied in Escherichiac oli (Strub et al. 2003) . More specifically,p roteins could be labeled with ac ombination of selenomethionine ands elenocysteine, thereby increasing thep otential number of heavy atom scatterers within the crystal. As does selenomethionine incorporation, selenocysteine labeling often results in ahighly isomorphous protein, allowing evendisulfidebond formation. Strub et al.( 2003) suggest that 88%-93%ofall proteins would be open to MADphasing using dual labeling.
Materials and methods

Cell growth and labeling
All culture media andsupplements were obtained from GIBCO. L-Selenomethioninew as obtainedf romA natraceC orp.T he stable human embryonick idney (293-HEK) cell line (Invitrogen) expressingt he Tie2 ectodomain (1-452) fusedt ot he constantd omain of IgG (Fc)w as maintained in high-glucose DME supplemented with 10% fetal bovine serum, penicillin, streptomycin,a nd 150 m g/mL hygromycin.F or experiments assessings elenomethioninei ncorporation,c ellsw ere grownt o ; 80%-90%c onfluence in 15-cmd ishesu sing medial acking hygromycin.
Mass spectrometry
SDS-PAGE-resolvedp roteins were digested witht rypsin, and peptides were purified and fractionated on aPoros 50 R2 reverse phase micro-tip as described( Erdjument-Bromagee ta l. 1998). The resulting peptide pools werea nalyzed by matrix-assisted laserd esorption/ionization reflectron time-of-flight (MALDIReTOF) masss pectrometry using aB rukerUltraFlexT OF/TOF instrument (Bruker Daltonik GmbH) as described (Winkler et al. 2002) . Selected experimental masses ( m / z )w ere then takent o search anonredundant protein database(NR) (3,245,378 entries on January 28,2 006; National Centerf or Biotechnology Information, Bethesda, MD)u singt he PeptideSearch algorithm (Matthias Mann, Max-Planck Institute for Biochemistry, Martinsried, Germany).( An updated version of this program is currently available as PepSea from Applied Biosystems/MDS Sciex.)Amolecular weight range twice thep redicted weight was covered, with massa ccuracyr estriction better than 40 ppm and amaximum of one missed cleavage site allowedper peptide. Massspectrometric sequencing of selected peptides was done by MALDI-TOF/TOF (MS/MS) analysis on thes ame prepared samples, beforea nd after selenomethionine labeling,u sing the LIFTm odeo ft he instrument. Fragment ions pectra were taken to search theN Rd atabaseu sing theM ASCOTM S/MS IonSearch program,version 2.0.04 forWindows (MatrixScience Ltd.) (Perkins et al.1 999) .A ny identificationt hus obtained wasv erifiedb y comparingt he computer-generated fragment ions erieso ft he predictedt ryptic peptidewitht he experimental MS/MSd ata.
Large-scale protein production
Forl arge-scalep rotein production of human Angiopoietin-2 receptor-binding domain (hAng2),s table HEK293 cells were grown to 80%-90% confluence in roller-bottle culture. Intracellular methionine pools were depleted with a1 2-h incubation in DME (lacking L-methionine or L-cysteine) supplemented with 30 mg/L L-cystine-2HCl, and 10% FBS.
It is importantt on ote that all cell media up to this point can be pooled,a nd the secreted unlabeled protein purifieda nd used for structural or others tudies. Following the preincubation, the media were replaced with DME supplemented with 60 mg/L L-selenomethionine,3 0m g/L L-cystine-2HCl, and1 0% FBS. Thec ellsw ere cultured for an additional 48 hp rior to media harvest.The media were clarifiedbyfiltration, andrecombinant secreted Angiopoietin-2-Fc wasp urified by affinity chromatography on rProteinA-Sepharose (GE Healthcare). The Fc tagwas removedw itht hrombin. Additional purification on an SD200 gelfiltration column (GE Healthcare) removedthe fusion tagas well as residual contaminants. N-terminal sequencing confirmed thei dentity of thep roduct, andm ass s pectrometry documented a93% substitution ratefor themethioninesinthe AngiopoietinderivedA TTMMIRPADFGSp eptide.
Protein crystallization and structured etermination
The purified hAng2 was concentrated to ; 15 mg/mL in abuffer containing 10 mM HEPES (pH7 .0), 200m MN aCl and crystallizeda tr oomt emperature by hanging-drop vapord iffusion against ar eservoir containing 0.2Mammonium sulfate, 0.1 Ms odiuma cetate (pH5 .2), and2 2% PEG-4000. Crystals weret ransferred to mother liquorw ith 20%g lycerolf or flashfreezing. A1.8 A˚SADdataset was collectedatNSLSbeamline X9A. Alldatawere processed using DENZO and SCALEPACK (Otwinowskia nd Minor1 997).T he selenium atomp ositions were determinedu sing SnBa nd inputi nto autoSHARP (Evans andB ricogne 2002) andu sedt oc alculateasolventf lattened map of excellent quality.T he space group is C2 with a ¼ 140.28 A˚, b ¼ 94.56 A˚, c ¼ 84.60 A˚, b ¼ 94.81°,a nd four independent molecules in the asymmetric unit. Model building was initially performed using Arp/Warp (CCP4 1994) and later proceeded through an iterative process of building in Oand refinement of the model in CNS (Jones et al. 1991; Brunger et al. 1998) . Stereochemical analysis of the refined models using PROCHECK of the CCP4 Package (CCP4 1994) revealed main-chain and side-chain parameters better than or within the typical range of values for protein structures determined at corresponding resolutions.
